Emerging role of RAB GTPases in cancer and human disease

Kwai W. Cheng, John P. Lahad, Joseph W. Gray, Gordon B. Mills

Research output: Contribution to journalReview articlepeer-review

181 Scopus citations


Emerging evidence implicates alterations in the RAB small GTPases and their associated regulatory proteins and effectors in multiple human diseases including cancer. We have recently shown that RAB25, located at chromosome 1q22, is amplified at the DNA level and overexpressed at the RNA level in ovarian and breast cancer. These changes correlated with a worsened outcome in both diseases. In addition, enforced expression of RAB25 in both breast and ovarian cancer cells decreased apoptosis and increased proliferation and aggressiveness in vivo, potentially explaining the worsened prognosis. A better understanding of genetic alterations as well as the physiologic and pathophysiologic roles of RAB GTPases may open new opportunities for therapeutic intervention and better outcomes.

Original languageEnglish (US)
Pages (from-to)2516-2519
Number of pages4
JournalCancer Research
Issue number7
StatePublished - Apr 1 2005
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Emerging role of RAB GTPases in cancer and human disease'. Together they form a unique fingerprint.

Cite this